Altair Therapeutics Report issue

For profit Phase 2
Founded: San Diego CA United States (2007)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2008
NCT00658749
First Marketed Drug
2010
pheniramine (Tripoton)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

ALTAIRE PHARMS INC | Altair Therapeutics, Inc.